医学临床研究
  2025年7月11日 星期五           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2024, Vol. 41 Issue (4): 572-575    DOI: 10.3969/j.issn.1671-7171.2024.04.026
  论著 本期目录 | 过刊浏览 | 高级检索 |
重组人干扰素α2b凝胶联合阿奇霉素治疗慢性宫颈炎伴HPV感染患者的临床疗效
谢菲, 李双*
西电集团医院药剂科,陕西 西安 710077
Effects of Using Recombinant Human Interferon α2b Gel in Combination with Azithromycin in Patients with Chronic Cervicitis Accompanied by HPV Infection
XIE Fei, LI Shuang
Department of Pharmacy,XD Group Hospital, Xi'an Shaanxi 710077
全文: PDF (1162 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨重组人干扰素α2b凝胶联合阿奇霉素治疗慢性宫颈炎伴人乳头瘤病毒(HPV)感染患者的临床疗效。【方法】选取2021年3月至2023年3月本院收治的110例慢性宫颈炎伴HPV感染患者,按随机数字表法分为对照组和观察组,每组55例。对照组采用重组人干扰素α2b凝胶治疗,观察组采用重组人干扰素α2b凝胶联合阿奇霉素治疗,均治疗14 d。比较两组患者临床疗效、乳酸杆菌减少率、白细胞酯酶(LE)阳性率、凝固酶(GADP)阳性率、阴道pH值>4.5占比、炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-8(IL-8)]水平、HPV病毒载量、HPV转阴率及疾病复发率。【结果】观察组总有效率高于对照组,差异有统计学意义(P<0.05)。观察组乳酸杆菌减少率、LE阳性率、GADP阳性率、阴道pH值>4.5占比均高于对照组,差异有统计学意义(P<0.05)。治疗前,两组炎症因子水平比较,差异无统计学意义(P>0.05);治疗后,观察组TNF-α、IL-1β、IL-8水平均低于对照组,差异有统计学意义(P<0.05)。治疗后,两组病毒载量均下降,且观察组病毒载量低于对照组,差异有统计学意义(P<0.05)。观察组HPV转阴率高于对照组,复阳率、疾病复发率低于对照组,差异有统计学意义(P<0.05)。【结论】重组人干扰素α2b凝胶联合阿奇霉素治疗慢性宫颈炎伴HPV感染患者的效果显著,可降低炎症因子水平,减少HPV病毒载量,促进HPV转阴,值得临床推广。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
谢菲
李双
关键词 宫颈炎/药物疗法乳头状瘤病毒感染/药物疗法干扰素α2叠氮红霉素    
Abstract:【Objective】To explore the application effect of recombinant human interferon α2b gel combined with azithromycin in patients with chronic cervicitis with HPV infection. 【Methods】A total of 110 patients with chronic cervicitis with HPV infection who were admitted to the XD Group Hospital from March 2021 to March 2023 were selected as the research objects. They were divided into the control group and the observation group by random number table method, with 55 cases in each group. The control group was treated with recombinant human interferon α2b gel, while the observation group was treated with recombinant human interferon α2b gel combined with azithromycin. Both treatments were for a course of 2 weeks. The clinical efficacy, Lactobacillus reduction rate, leukocyte esterase (LE) test and coagulase (GADP), vaginal pH value, inflammation factors [tumor necrosis factor-α (TNF-α), interleukin-1β(IL-1β), interleukin-8(IL-8)]level, HPV virus load, conversion rate, and recurrence rate of the two groups were compared. 【Results】The total effective rate of the study group was higher than that of the control group, and the difference was statistically significant (P<0.05). The reduction rate of Lactobacillus, positive rate of LE, positive rate of GADP, and proportion of vaginal pH value >4.5 in the observation group were all higher than those in the control group, and the differences were statistically significant (P<0.05). Before treatment, there was no statistical significance in the comparison of inflammation factors between the two groups (P>0.05). After treatment, the levels of TNF-α, IL-1β, and IL-8 in the observation group were lower than those in the control group, the difference was statistically significant (P<0.05). After treatment, the virus load of both groups decreased, while the virus load of the observation group was lower than that of the control group, and the difference was statistically significant (P<0.05). The HPV negative conversion rate of the observation group was higher than that of the control group, the HPV recurrence rate and the disease recurrence rate in the observation were lower than those in the control group, and the differences were statistically significant (P<0.05). 【Conclusion】Recombinant human interferon α2b gel combined with azithromycin has significant effects in patients with chronic cervicitis with HPV infection. It can reduce inflammation, reduce HPV virus load, promote HPV negative conversion, which is worth promoting.
Key wordsUterine Cervicitis/DT    Papillomavirus Infections/DT    Interferon alpha-2    Azithromycin
收稿日期: 2023-06-30     
中图分类号:  R711.32  
通讯作者: *E-mail:m15029222138-1@163.com   
引用本文:   
谢菲, 李双. 重组人干扰素α2b凝胶联合阿奇霉素治疗慢性宫颈炎伴HPV感染患者的临床疗效[J]. 医学临床研究, 2024, 41(4): 572-575.
XIE Fei, LI Shuang. Effects of Using Recombinant Human Interferon α2b Gel in Combination with Azithromycin in Patients with Chronic Cervicitis Accompanied by HPV Infection. JOURNAL OF CLINICAL RESEARCH, 2024, 41(4): 572-575.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.04.026     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I4/572
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn